INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo GURONSAN C [EFFERVESCENT TABLETS]
SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form):

GURONSAN C [EFFERVESCENT TABLETS]

COMPOSITION:
Each tablet contains:
Caffeine         50,0 mg
Glucuronamide         20,0 mg
Ascorbic Acid (Vit. C)         500,0 mg
Glucuronolactone         30,0 mg

PHARMACOLOGICAL CLASSIFICATION:
A33 Tonics

INDICATIONS:
A tonic for fatigue.

CONTRA-INDICATIONS:
Guronsan C is contra-indicated in patients with hyperoxaluria, peptic ulceration, hyper-thyroidism, hypertension, cardiac arrythmias, or other cardiovascular disease, uncontrolled seizure disorders, insomnia and anxiety disorders as these may be exacerbated.

DOSAGE AND DIRECTIONS FOR USE:
Drop one tablet in half a glass of water. The tablet quickly dissolves producing a good-tasting, effervescent drink. Cold water is recommended for a more pleasant taste. Drink the mixture as soon as the tablet is dissolved. Take one or two tablets daily, depending on the severity of the symptoms.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Glucuronamide/Glucuronolactone
No known side-effects have been reported.
Ascorbic Acid [Vitamin C]
Large doses may cause diarrhoea, other gastro-intestinal disturbances.
Caffeine
Gastro-intestinal irritation including nausea, vomiting, abdominal pain, diarrhoea and gastro-intestinal bleeding, insomnia, headache, anxiety, restlessness, dizziness and palpitations.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
“Glucuronamide/Glucuronolactone”Component
Treatment is supportive and symptomatic.
“Ascorbic Acid”Component
Diarrhoea or other gastro-intestinal disturbances. Treatment is supportive and symptomatic.
“Caffeine”Component
Overdosage or idiosyncrasy may lead to agitation, anxiety, confusion, delirium and convulsions. Headache, vomiting, dehydration, fever, tinnitus and urinary frequency may occur. Severe toxicity may not be preceded by milder symptoms.
Treatment
In cases of overdosage, consult a doctor immediately. Treatment is supportive and symptomatic.

IDENTIFICATION:
A flat yellowish-while bisected tablet with bevelled edges. A logo and letters “C S K”appear engraved on one side.

PRESENTATION:
Polypropylene tubes containing 10 tablets.

STORAGE INSTRUCTIONS:
Since the tablets are not to absorb moisture, the container should be sealed tightly after each use and kept in a dry place. Store below 25°C. KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
G/33/2480

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pharmacare Limited
7 Fairclough Road
Korsten
Port Elizabeth
6020

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
28/07/1997

Manufactured under licence for: Chugai Pharmaceutical Co. Ltd. Japan

                G448
        KOHLER C&P P.E.

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996,1997,1998